237: How Does the Use of Concomitant Methotrexate Affect the Efficacy and Safety of Biologics for Psoriatic Arthritis?

Sunday, November 13, 2022

6:30 PM – 8:30 PM Eastern Time

Location: Room 118BC

All of the relevant financial relationships listed for faculty have been mitigated.

Industry Presenter(s)

Grace Wright, MD, PhD, FACR

President & CEO
Grace C Wright MD PC
New York, NY, United States

Disclosure information not submitted.
AS

Anthony Sebba, MD

Assistant Clinical Professor
Arthritis Associates
Palm Harbor, FL, United States

Disclosure information not submitted.
Alexis Ogdie, MD

Rheumatologist, Associate Professor of Medicine
University of Pennsylvania
Philadelphia, PA, United States

Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead Sciences: Consultant (Ongoing); GlaxoSmithKline: Consultant (Ongoing); Happify Health: Consultant (Ongoing); Janssen: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing)

Lilly Medical is excited to provide an interactive psoriatic arthritis patient case discussion of the high level efficacy and safety of biologics with and without Methotrexate.

Developed and offered by Lilly Medical